230 related articles for article (PubMed ID: 8475411)
1. Drug resistance modulation in the laboratory and the clinic.
Dalton WS
Semin Oncol; 1993 Feb; 20(1):64-9. PubMed ID: 8475411
[No Abstract] [Full Text] [Related]
2. [Reversal of drug resistance and prediction of the response to cytostatics. Experimental drug therapy for tumors has clinical potential].
Larsson R; Nygren P; Bergh J
Lakartidningen; 1991 Dec; 88(51-52):4441-4. PubMed ID: 1774991
[No Abstract] [Full Text] [Related]
3. [Resistance, the cause of failure in antineoplastic chemotherapies].
Israel L
Pathol Biol (Paris); 1989 Feb; 37(2):125-7. PubMed ID: 2652060
[No Abstract] [Full Text] [Related]
4. Cancer robustness: tumour tactics.
Kitano H
Nature; 2003 Nov; 426(6963):125. PubMed ID: 14614483
[No Abstract] [Full Text] [Related]
5. [Multidrug resistance].
Donenko FV; Sitdikova SM; Moroz LV
Vopr Onkol; 1991; 37(7-8):780-8. PubMed ID: 1842629
[No Abstract] [Full Text] [Related]
6. Combination chemotherapy--theory and practice.
Capizzi RL; Keiser LW; Sartorelli AC
Semin Oncol; 1977 Jun; 4(2):227-53. PubMed ID: 327555
[No Abstract] [Full Text] [Related]
7. [The mechanisms of the resistance of malignant cells to cytostatics].
Reichle A; Diddens H; Rastetter J; Berdel WE
Dtsch Med Wochenschr; 1991 Feb; 116(5):186-91. PubMed ID: 1993424
[No Abstract] [Full Text] [Related]
8. BMS and Exelixis target tumor suppression pathways.
Expert Rev Anticancer Ther; 2001 Aug; 1(2):167. PubMed ID: 12113021
[No Abstract] [Full Text] [Related]
9. [Oncobiogram and its significance in the choice and efficacy of cytostatic therapy].
Savran VR
Vopr Onkol; 1983; 29(3):106-13. PubMed ID: 6340347
[No Abstract] [Full Text] [Related]
10. Introduction to resistance to anticancer agents.
Kruh GD
Oncogene; 2003 Oct; 22(47):7262-4. PubMed ID: 14576836
[No Abstract] [Full Text] [Related]
11. [Drug resistance in malignant neoplasms].
Czownicki Z
Pol Tyg Lek; 1982 Apr; 37(6):173-5. PubMed ID: 7122313
[No Abstract] [Full Text] [Related]
12. [Recent progress in the study of drug resistance in cancer cells].
Liu J; Xu B
Sheng Li Ke Xue Jin Zhan; 1989 Apr; 20(2):158-60. PubMed ID: 2686016
[No Abstract] [Full Text] [Related]
13. [Resistance of cancer cells to antineoplastic agents. Can the efficiency of chemotherapy be predicted?].
Bénard J
Rev Prat; 1992 Feb; 42(3):318-9. PubMed ID: 1579821
[No Abstract] [Full Text] [Related]
14. Intrinsic versus acquired drug resistance.
Mackillop WJ
Cancer Treat Rep; 1986 Jun; 70(6):817-8. PubMed ID: 3731144
[No Abstract] [Full Text] [Related]
15. Drug resistance mediated by cellular stress response to the microenvironment of solid tumors.
Tomida A; Tsuruo T
Anticancer Drug Des; 1999 Apr; 14(2):169-77. PubMed ID: 10405643
[TBL] [Abstract][Full Text] [Related]
16. [General observation on drug resistance of cancer cells].
Inaba M
Gan To Kagaku Ryoho; 1982 Feb; 9(2):165-76. PubMed ID: 6764100
[TBL] [Abstract][Full Text] [Related]
17. Using biomarkers in drug development.
Workman P
Clin Adv Hematol Oncol; 2006 Oct; 4(10):736-9. PubMed ID: 17099630
[No Abstract] [Full Text] [Related]
18. High-content assays in oncology drug discovery: opportunities and challenges.
Mouchet EH; Simpson PB
IDrugs; 2008 Jun; 11(6):422-7. PubMed ID: 18509783
[TBL] [Abstract][Full Text] [Related]
19. The convergence of cancer prevention and therapy in early-phase clinical drug development.
Abbruzzese JL; Lippman SM
Cancer Cell; 2004 Oct; 6(4):321-6. PubMed ID: 15488755
[TBL] [Abstract][Full Text] [Related]
20. Prediction of responses to therapy and mechanisms of resistance.
Hall TC
Semin Oncol; 1977 Jun; 4(2):193-202. PubMed ID: 327553
[No Abstract] [Full Text] [Related]
[Next] [New Search]
